Skip to content

CyberKnife

RADIATION15 trials

Sponsors

Beth Israel Deaconess Medical Center, Centre Oscar Lambret, Stanford University, Albert Koong, Wake Forest University Health Sciences

Conditions

Adenocarcinoma of the PancreasCarcinoma, HepatocellularColorectal CancerGlioblastoma MultiformeHepatocellular CarcinomaHigh Grade GliomasLiver NeoplasmsLung Cancer

Phase 1

Phase 2

Phase 3

Unknown Phase

Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
TerminatedNCT01188486
Stanford UniversityLung Cancer, Lung Cancer Non-Small Cell Cancer (NSCLC), Lung Cancer Small Cell Lung Cancer (SCLC) +1
Start: 2010-08-31End: 2017-04-30Updated: 2018-04-17
Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
WithdrawnNCT01847495
Wake Forest University Health SciencesColorectal Cancer
Start: 2013-10-31End: 2017-11-29Updated: 2024-10-04
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
RecruitingNCT01890590
Beth Israel Deaconess Medical CenterRenal Cell Carcinoma
Start: 2013-07-31End: 2025-03-31Target: 46Updated: 2024-08-15
CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer
CompletedNCT01985828
Wake Forest University Health SciencesProstate Adenocarcinoma
Start: 2013-11-19End: 2019-08-31Updated: 2024-10-03
Stereotactic Radiosurgery for Soft Tissue Sarcoma
WithdrawnNCT02706171
The Cooper Health SystemSoft Tissue Sarcoma
Start: 2015-06-30End: 2018-12-31Updated: 2024-03-15
Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife
CompletedNCT02716207
Changhai HospitalPancreatic Tumor
Start: 2016-03-31End: 2020-12-31Updated: 2021-05-14
Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma
NCT03284151
Centre Francois Baclesse, LuxembourgProstate Cancer
Start: 2015-01-31End: 2023-01-31Updated: 2022-06-22
Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma
RecruitingNCT04998552
Capital Health System, IncPancreas Adenocarcinoma
Start: 2021-06-22End: 2027-06-22Target: 10Updated: 2023-03-31

Related Papers